Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 73 M72 M68 M68 M73 M69 M 278 M Research & development —————— — Operating income 44 M30 M98 M79 M-15 M14 M 176 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized 12 M12 M12 M13 M12 M15 M 52 M Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income 33 M20 M88 M58 M-6 M1 M 141 M Equity in earnings —————— — Taxes 6 M5 M31 M25 M-3 M12 M 65 M Non-controlling/minority interest —————— — After tax other income/expense ————19 M1 M — Net income before discontinued operations 27 M15 M57 M33 M-3 M-11 M 76 M Discontinued operations —————— — Net income 27 M15 M57 M33 M-3 M-11 M 76 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 27 M15 M57 M33 M-3 M-11 M 76 M Basic earnings per share (Basic EPS) 0.660.371.430.83-0.08-0.28 1.9 Diluted earnings per share (Diluted EPS) 0.650.371.410.81-0.08-0.28 1.86 Average basic shares outstanding 40.6 M40.6 M40 M40.1 M39.6 M39.8 M — Diluted shares outstanding 41.5 M41.1 M40.3 M40.7 M39.6 M39.8 M — EBITDA 135 M117 M194 M166 M84 M95 M 539 M EBIT 77 M72 M145 M121 M43 M52 M 361 M Cost of revenue 662 M640 M624 M690 M630 M674 M 2.62 B Other cost of goods sold 662 M640 M624 M690 M630 M674 M 2.62 B Depreciation & amortization (cash flow) 40 M45 M49 M45 M41 M43 M 178 M